What is the address of KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN?

The registered office of KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN is located at Doelenstraat 18A, 3920 Lommel.

Is KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN still active?

Yes. According to the CBE (30 September 2026) KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN is active, legal situation “Normale toestand”, started on 13 December 2019.

Is KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN registered on Peppol?

No, KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN is currently not registered on the Peppol network.

What is the enterprise number of KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN?

The enterprise number of KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN is BE0739597977.

When was KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN founded?

KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN was founded on 13 December 2019.

Who are the directors of KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN?

According to the 2025 annual accounts, the directors of KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN are: Nick Vernelen.

Is KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 December 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN make in 2025?

KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN posted a profit after taxes of € 24,441 in financial year 2025.

What is the revenue of KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN?

As a small company, KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 33,708.

KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN (Private Limited)

Dossier KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN, printed on 30 September 2026 from databakkes.be/en/0739597977/kinesitherapie-osteopathie-nick-vernelen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN from Lommel, company number BE0739597977, closed financial year 2025 with a result of € 24,441 after tax. For that financial year KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN recorded a gross margin of € 33,708 and equity of € 1,000. Compared with financial year 2024, the result moved from € 22,872 to € 24,441. Profitable, and profit is growing. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 13, 2026.

What it is worth Shrank hard

€ 1,000

▼ 99% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 24,441

▲ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 29,463

▼ 64% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 110,591 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 656

▼ 16% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 31,737 Gross margin 2022: € 31,737 First fiscal year in the series	€ 46,597 Gross margin 2023: € 46,597 ▲ 47% vs 2022 (€ 31,737) Favourable step	€ 32,396 Gross margin 2024: € 32,396 ▼ 30% vs 2023 (€ 46,597) Unfavourable step	€ 33,708 Gross margin 2025: € 33,708 ▲ 4% vs 2024 (€ 32,396) Favourable step	▲ 4%
Profit after taxes	€ 19,570 Profit after taxes 2022: € 19,570 First fiscal year in the series	€ 35,748 Profit after taxes 2023: € 35,748 ▲ 83% vs 2022 (€ 19,570) Favourable step	€ 22,872 Profit after taxes 2024: € 22,872 ▼ 36% vs 2023 (€ 35,748) Unfavourable step	€ 24,441 Profit after taxes 2025: € 24,441 ▲ 7% vs 2024 (€ 22,872) Favourable step	▲ 7%
Equity	€ 34,164 Equity 2022: € 34,164 First fiscal year in the series	€ 65,111 Equity 2023: € 65,111 ▲ 91% vs 2022 (€ 34,164) Favourable step	€ 87,150 Equity 2024: € 87,150 ▲ 34% vs 2023 (€ 65,111) Favourable step	€ 1,000 Equity 2025: € 1,000 ▼ 99% vs 2024 (€ 87,150) Unfavourable step	▼ 99%
Total debts	€ 28,433 Total debts 2022: € 28,433 First fiscal year in the series	€ 28,867 Total debts 2023: € 28,867 ▲ 2% vs 2022 (€ 28,433) Unfavourable step	€ 10,603 Total debts 2024: € 10,603 ▼ 63% vs 2023 (€ 28,867) Favourable step	€ 37,034 Total debts 2025: € 37,034 ▲ 249% vs 2024 (€ 10,603) Unfavourable step	▲ 249%
Cash	€ 55,456 Cash 2022: € 55,456 First fiscal year in the series	€ 77,394 Cash 2023: € 77,394 ▲ 40% vs 2022 (€ 55,456) Favourable step	€ 80,733 Cash 2024: € 80,733 ▲ 4% vs 2023 (€ 77,394) Favourable step	€ 29,463 Cash 2025: € 29,463 ▼ 64% vs 2024 (€ 80,733) Unfavourable step	▼ 64%
Retained profit	€ 33,164 Retained profit 2022: € 33,164 First fiscal year in the series	€ 64,111 Retained profit 2023: € 64,111 ▲ 93% vs 2022 (€ 33,164) Favourable step	€ 86,150 Retained profit 2024: € 86,150 ▲ 34% vs 2023 (€ 64,111) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 86,150) Unfavourable step	▼ 100%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 4,800 Dividend 2023: € 4,800 ▲ € 4,000 vs 2022 (€ 800) Unchanged	€ 833 Dividend 2024: € 833 ▼ 83% vs 2023 (€ 4,800) Unchanged	€ 110,591 Dividend 2025: € 110,591 ▲ € 109,758 vs 2024 (€ 833) Unchanged	▲ € 109,758
Balance sheet total	€ 62,596 Balance sheet total 2022: € 62,596 First fiscal year in the series	€ 93,979 Balance sheet total 2023: € 93,979 ▲ 50% vs 2022 (€ 62,596) Unchanged	€ 97,753 Balance sheet total 2024: € 97,753 ▲ 4% vs 2023 (€ 93,979) Unchanged	€ 38,034 Balance sheet total 2025: € 38,034 ▼ 61% vs 2024 (€ 97,753) Unchanged	▼ 61%

Key figures of KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN?

What happened at KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 13, 2026 New annual accounts for financial year 2025: profit of € 24,441 (▲ 7% vs 2024). Source: NBB ↗
Dec 13, 2019 New establishment in Lommel. KBO
2019 Nick Vernelen became a director. NBB
Dec 13, 2019 Start of the company according to the CBE. KBO

In short

From € 19,570 profit in 2022 to € 24,441 profit in 2025.

Paid € 28,038 in corporate taxes since 2022.

Best year ever: 2023, with € 35,748 profit.

Paid out € 117,024 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN? We notify you, reason included.

Follow KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Nick Vernelen

KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN

Behind KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN is Nick Vernelen.

See the full network in the app

Directors

According to the 2025 annual accounts

Nick Vernelen

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Doelenstraat 18A

3920 Lommel

2.297.446.978

Kerkhovensesteenweg 359

3920 Lommel

Active since 13 December 2019

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0739.597.977
VAT number: BE 0739.597.977
Registered office: Doelenstraat 18A, 3920 Lommel
Names & denominations: KINESITHERAPIE/OSTEOPATHIE NICK VERNELEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 13 December 2019
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗